Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.

PMID: BMC Cancer. 2022 May 20; 22 (1): 566. Epub 2022 May 20. PMID: 35596224 Abstract Title: Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota. Abstract: BACKGROUND: The role of Berberine (BBR) in colorectal cancer (CRC) and gut microbiota has begun to appreciate. However, there was no … Read more

Screening of immune-related genes and predicting the immunotherapeutic effects of formononetin in breast cancer.

PMID: Evid Based Complement Alternat Med. 2022; 2022: 9942373. Epub 2022 Apr 15. PMID: 35463082 Abstract Title: Screening of Immune-Related Genes and Predicting the Immunotherapeutic Effects of Formononetin in Breast Cancer: A Bioinformatics Analysis. Abstract: Objective: Immunotherapy is a promising breast cancer treatment. Nonetheless, tumor heterogeneity and the interaction between immune cells in the tumor … Read more